Follow
Lie Ma
Title
Cited by
Cited by
Year
CRISPR/Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse
Y Guan, Y Ma, Q Li, Z Sun, L Ma, L Wu, L Wang, L Zeng, Y Shao, Y Chen, ...
EMBO molecular medicine 8 (5), 477-488, 2016
2092016
Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD
BH Koehn, A Saha, C McDonald-Hyman, M Loschi, G Thangavelu, L Ma, ...
Blood 134 (19), 1670-1682, 2019
602019
Enhanced genome editing to ameliorate a genetic metabolic liver disease through co-delivery of adeno-associated virus receptor
S Yin, L Ma, T Shao, M Zhang, Y Guan, L Wang, Y Hu, X Chen, H Han, ...
Science China Life Sciences, 1-13, 2020
202020
Generation of Human Myeloid Derived Suppressor Cells from Induced Pluripotent Stem Cells (IPSC) for Graft versus Host Disease Therapy
L Ma, BH Koehn, KD Smith, A Mehta, KL Hippen, V Bob, BR Blazar
MOLECULAR THERAPY 30 (4), 349-350, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–4